" /> Triosephosphate isomerase deficiency - CISMeF





Preferred Label : Triosephosphate isomerase deficiency;

Symbol : TPID;

CISMeF acronym : TPID;

Type : Phenotype, molecular basis known;

Description : Triosephosphate isomerase (TPI) deficiency is an autosomal recessive multisystem disorder characterized by congenital hemolytic anemia, progressive neuromuscular dysfunction, susceptibility to bacterial infection, and cardiomyopathy. Homozygotes exhibit markedly reduced enzyme activity in all tissues studied, accompanied by metabolic block in glycolysis with intracellular accumulation of dihydroxyacetonephosphate (DHAP), particularly in red blood cells, which lack the capacity to metabolize DHAP in the glycerophosphate shuttle via alpha-glycerophosphate dehydrogenase. Heterozygotes have approximately 50% normal TPI activity, but manifest no evidence of metabolic block or clinical effects, implying that this level of enzyme activity is sufficient to maintain normal metabolic function (summary by Ationu et al., 1999).;

Inheritance : Autosomal recessive;

Molecular basis : Caused by mutation in the triosephosphate isomerase-1 gene (TPI1, 190450.0001);

Laboratory abnormalities : Increased levels of dihydroxyacetone phosphate (DHAP) in tissues and red cells; Decreased activity of triosephosphate isomerase;

Prefixed ID : #615512;

Details


You can consult :


Nous contacter.
10/06/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.